How is the Sarepta Therapeutics Inc today?

The Sarepta Therapeutics Inc today is trading in the green, up by 1.72% at 39.54.

How has Sarepta Therapeutics Inc performed historically?

The Sarepta Therapeutics Inc is currently trading up 1.72% on an intraday basis in the past week the index rose 6.20%. The index has been down -61.56% in the past quarter and fell -66.97% in the past year. You can view this in the overview section.

What is Sarepta Therapeutics Inc Annual Revenue?

Sarepta Therapeutics Inc Annual Revenue rose 52.97%, in the last year to $1,901.98 M. Its sector's average revenue growth for the last fiscal year was 8.76%.

What is Sarepta Therapeutics Inc Annual Net Profit?

Sarepta Therapeutics Inc Annual Net Profit rose 143.89% in the last year to $235.24 M. Its sector's average net profit growth for the last fiscal year was -13.86%.

What is Sarepta Therapeutics Inc Price to Earning Ratio?

Sarepta Therapeutics Inc Price to Earning Ratio is -15.64, which is negative.

What is Sarepta Therapeutics Inc Stock Price?

Sarepta Therapeutics Inc Stock Price fell 66.97% and underperformed its sector by 95.41% in the past year.

What is Sarepta Therapeutics Inc Quarterly Revenue?

Sarepta Therapeutics Inc Quarterly Revenue rose 80.15% YoY to $744.86 M. Its sector's average revenue growth YoY for the quarter was 3.14%.

What is Sarepta Therapeutics Inc Quarterly Net profit?

Sarepta Therapeutics Inc Quarterly Net profit fell 1,338.98% YoY to $447.51 M. Its sector's average net profit growth YoY for the quarter was -238.4%.

What is Sarepta Therapeutics Inc Debt to Equity Ratio?

Sarepta Therapeutics Inc Debt to Equity Ratio of 0.88 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Sarepta Therapeutics Inc Return on Equity(ROE)?

Sarepta Therapeutics Inc Return on Equity(ROE) for the last financial year was 19.71%, in the normal range of 10% to 20%.

What is Sarepta Therapeutics Inc Mutual Fund Holding?

Sarepta Therapeutics Inc Mutual Fund Holding decreased by 2.32% in the last quarter to 78.69.

What is Sarepta Therapeutics Inc Promoter Share Holding?

Sarepta Therapeutics Inc Promoter Share Holding increased by 0.17% in the most recent quarter to 6.3%.

What is Sarepta Therapeutics Inc Interest Coverage Ratio?

Sarepta Therapeutics Inc Interest Coverage Ratio is 15.18, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).

What is Sarepta Therapeutics Inc Institutional Holding?

Sarepta Therapeutics Inc Institutional Holding decreased by 0.17% in the last quarter to 91.85.

Sarepta Therapeutics Inc XNAS: SRPT

Sarepta Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Name: Sarepta Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Sarepta Therapeutics Inc
Rating: 1.787208375
Author: Trendlyne DVM scores

Expensive Underperformer

about

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targ...

39.54 0.67 (1.72%)

77.18% Fall from 52W High

2.3M XNAS Volume

XNAS 04 Jun, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for Sarepta Therapeutics Inc is on 06 Jun 2025 for the purpose of Sarepta Therapeutics Inc Annual General Meeting for 2025 See details

Medium Financial Strength

50.0 / 100

Expensive Valuation

20.2 / 100

Technically Bearish

22.8 / 100

Expensive Underperformer These stocks are medium in financial scores. They have bad valuation and technical scores as well. View Similar Embed DVM

1Yr Price target upside is 128%

25 analysts

Sarepta Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Sarepta Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targ...

77.18% Fall from 52W High

SWOT Analysis

Sarepta Therapeutics Inc Live Price Chart

Sarepta Therapeutics Inc FAQ

How is Sarepta Therapeutics Inc today?

Sarepta Therapeutics Inc today is trading in the green, and is up by 1.72% at 39.54.

How has Sarepta Therapeutics Inc performed historically?

Sarepta Therapeutics Inc is currently trading up 1.72% on an intraday basis. In the past week the stock rose 6.20%. stock has been down -61.56% in the past quarter and fell -66.97% in the past year. You can view this in the overview section.